To understand the progression of complex diseases such as cancer, scientists have had to tease out the interactions between cells at progressively finer scales — from the behavior of a single tumor cell in the body on down to the activity of that cell’s inner machinery.
If you want to understand a novel, it helps to start from the beginning rather than trying to pick up the plot from somewhere in the middle. The same goes for analyzing a strand of DNA. The best way to make sense of it is to look at it head to tail.
Under the terms of the expanded agreement, Abbott Animal Health will obtain exclusive license and distribution rights to the products for essentially the entire world. In return, Oasmia will receive an upfront payment and is eligible to receive additional milestone payments of up to $21.5M subject to Oasmia meeting various product development and sales milestones. In addition, in the event either or both of the products are commercialized, Oasmia shall receive tiered royalties on net sales. Oasmia will continue to fund research, development and manufacture of Paccal® Vet and Doxophos® Vet.
Interventional radiologists at Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center (Midwestern) performed the first Nanoknife procedure in Illinois, using electricity to target hard to access tumors. The technology, called NanoKnife®, uses electrical impulses to effectively break up tumors and destroy cancer cells that may otherwise be inoperable or allow for few treatment options due to their proximity to major arteries, airways and other vulnerable tissues. The NanoKnife procedure is commonly used to treat tumors located in the liver or pancreas.
A noted researcher in nanomedicine — preventing, diagnosing and treating disease with particles so small that thousands fit across the width of a human hair — will deliver the inaugural presentation in "The Kavli Foundation Emerging Leader in Chemistry Lecture" at the next National Meeting of the American Chemical Society (ACS).
Plasmonic gold nanoparticles make pinpoint heating on demand possible. Now Rice University researchers have found a way to selectively heat diverse nanoparticles that could advance their use in medicine and industry.
NanoViricides, Inc. (the "Company") announced today that it has retained Id3A, LLC (“Id3A”), as the architect for its laboratory and cGMP pilot production facility project. As previously announced, this facility will be built by renovating an existing 18,000 sq. ft. light manufacturing plant on a 4.2 acre lot in Shelton, CT. Ms. Kathyann Cowles, AIA, will serve as the Principal Architect for the project. Id3A recently began working with the Company for the architecture portion and now the Company has formally engaged Id3A as the architects for this project.
As Twelfth Night approaches and the Christmas decorations start to look increasingly congruous as the last crumbs of cake are swept away and the remnants of the turkey have finally been consumed, there is the perennial question as to what to do with the tree. Research published in the International Journal of Biomedical Nanoscience and Nanotechnology suggests that the needles of the plant Pseudotsuga menziesii, commonly known as the Douglas fir could be used to sterilize nano devices destined for medical applications.
President Barack Obama named University of Missouri researcher M. Frederick Hawthorne as recipient of the National Medal of Science, the highest honor bestowed by the country to scientists. Hawthorne is the director of the International Institute of Nano and Molecular Medicine at the University of Missouri, as well as Curators' Distinguished Professor of Chemistry and Radiology.
Tufts University School of Engineering researchers have developed a novel method for fabricating collagen structures that maintains the collagen's natural strength and fiber structure, making it useful for a number of biomedical applications.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.